SlideShare a Scribd company logo
1 of 31
AdvancingDialysis.org
Recasting Kidney Failure are
Cardiovascular Disease
A STATE OF PERSISTENT FLUID OVERLOAD
AdvancingDialysis.org
ESRD:
Represents 7% of the Medicare Budget
TREATS ONLY 1% OF THE US POPULATION1
• The rising number and costs of the dialysis population continues to attract policy
makers attention.
‒ Policy makers including, the US Government Accountability Office, suggest
home therapies should be expanded and barriers addresses
• The challenge with increasing the use of home therapies centers on the type of
the dialysis modality used, how they are applied and the barriers to utilization
• The modalities need to address the chronic diseases which are major drivers of
morbidity and mortality as compared to “uremia”
• How home dialysis modalities address these chronic diseases and how patients
feel on therapy is the ongoing challenge to moving more patients to the home
setting while improving efficacy of therapy
1USRDS 2018 Vol 2 Figure 9.2: Trends in (a) total Medicare & ESRD fee-for-service spending ($, in billions),
and (b) ESRD spending as percentage of Medicare fee-for-service spending, 2004-2016
AdvancingDialysis.org
$19.9 Billion
$25.4 Billion
$29.2 Billion
$31.3 Billion
$32.9 Billion
$35.4 Billion
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
US DOLLARS
Inpatient Outpatient Physician/supplier Part D Drugs
Total Medicare Healthcare
Expenditures for Dialysis Patients
USRDS 2005 & 2018 Ref Table K.1: Total Medicare spending ($) of reported ESRD patients by claim type
STEADILY HAS RISEN TO MORE
THAN $35 BILLION/YEAR
AdvancingDialysis.org
Medicare per Capita
Expenditures have Stabilized
USRDS 2018 Ref Table K.6 & USRDS 2005 Ref Table K.5: Per person per year spending ($): dialysis patients, with
unknown modalities dropped (model 1); period prevalent patients, as-treated model, primary payer only, by age, sex,
race, ethnicity & primary diagnosis. 2005:as-treated model, Medicare primary payor only
$68,020
$80,099
$85,845 $89,689
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
MEDICARE DIALYSIS
EXPENDITURE PER PERSON
SPEND PER PATIENT:
RELATIVELY FLAT SINCE 2009
AdvancingDialysis.org
Dialysis Patient Population Increasing
2016 POPULATION: OVER 500,000+
USRDS 2018 Ref Table D.1: Percentages & counts of reported ESRD patients: by treatment modality incident
& December 31 point prevalent patients
343,015
382,976
414,503
443,649
478,681
509,014
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
US DIALYSIS PATIENTS
All Dialysis
INCREASED SPEND DRIVEN BY
INCREASED PATIENT CENSUS
AdvancingDialysis.org
Dialysis Patient Population Growth
SLOWING GROWTH RATE
USRDS 2018 Ref Table D.1: Percentages & counts of reported ESRD patients: by treatment modality incident
& December 31 point prevalent patients
3.7%
3.2%
3.8%
4.5% 4.4% 4.3%
3.8%
3.3%
2.4%
1.8%
3.7%
3.6%
3.3%
3.0% 3.0% 2.9%
3.0%
3.2%
3.4%
3.8%
2011-1
2011-2
2011-3
2011-4
2012-1
2012-2
2012-3
2012-4
2013-1
2013-2
2013-3
2013-4
2014-1
2014-2
2014-3
2014-4
2015-1
2015-2
2015-3
2015-4
2016-1
2016-2
2016-3
2016-4
2017-1
2017-2
2017-3
2017-4
ANNUALIZED POPULATION
GROWTH RATE (%)
Dialysis only Transplant only
GROWTH RATE:
FALLEN TO BELOW 2%
AdvancingDialysis.org
218.5
212.8
204.2
196.2
191.2
184.5
180.4
172.6 169.2 167.4 168.2 166.3
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
ANNUAL MORTALITY RATE
PER 1,000 PATIENT YEARS
Hemodialysis Peritoneal Dialysis
Annual Mortality
DIALYSIS DEATH RATES HAVE STABILIZED
USRDS 2018 Ref Tables H8 & H9: Annual mortality rates: Hemodialysis & CAPD/CCPD patients, adjusted for
age, sex, race, ethnicity, primary cause of ESRD, and patient vintage per 1,000 patient years at risk; period
prevalent patients, by age, sex, race, ethnicity, primary cause of ESRD, & patient vintage
HEMODIALYSIS DEATH RATE:
RELATIVELY FLAT SINCE 2013
AdvancingDialysis.org
Hospitalizations and Hospital Days
DIALYSIS HOSPITALIZATIONS HAVE STABILIZED
USRDS 2018 Ref Tables G2 & G7: Total admission rates: dialysis patients per 1,000 patient years, period prevalent
patients, by age, sex, race, ethnicity, primary diagnosis, & patient vintage; Hospital days: dialysis patients per patient
year, period prevalent patients, by age, sex, race, ethnicity, primary diagnosis, & patient vintage.
2.1 2.1 2.0 2.0 2.0 2.0 1.9 1.9 1.8 1.7 1.7 1.7
14.5 14.4 14.0 13.5 13.2 12.7 12.5 12.0 11.6 11.4 11.4 11.3
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
HOSPITALIZATION DAYS
PER PATIENT YEAR
HOSPITALIZATIONS PER
YEAR
Hospitalizations per year Hospital days per Patient Year
HOSPITALIZATIONS AND DAYS:
RELATIVELY FLAT SINCE 2013
AdvancingDialysis.org
Dialysis Patient Hospitalization Utilization
TRENDS SHOWING INCREASED USE OF EMERGENT CARE1,2
1Mean percentage of Medicare dialysis patients with ≥1 ER/OBS admission each week; 2014 – 2016
2Mean percentage of Medicare dialysis patients with ≥1 hospital admission each week; 2014 – 2016
MEDICARE DIALYSIS PATIENT
HOSPITALIZATIONS HAVE
STABILIZED2
EQUIVALENT UTILIZATION OF
EMERGENCY AND
OBSERVATIONAL ROOM CARE1
AdvancingDialysis.org
Management of Chronic Hypertension,
Left Ventricular Hypertrophy and Heart Failure
THE FATAL FLAW OF CONVENTIONAL DIALYSIS
AdvancingDialysis.org
Unmet Need in the
Causal Path of Heart Disease
CHRONIC FLUID OVERLOAD
1Rocco MV, Burkart JM. Prevalence of missed treatments and early sign-offs in hemodialysis patients. J Am
Soc Nephrol. 1993 Nov;4(5):1178-83.
Fluid
Overload
Uncontrolled
Hypertension
Left Ventricular
Hypertrophy
Heart Failure
Hospitalization
and Death
Early Sign-Offs
and No-Shows1
High
Ultrafiltration
Rate
Intradialytic
Hypotension
Cramping,
Dizziness,
Nausea, etc.
Long Post-
Dialysis
Recovery
Time
Poor HRQoL
Cardiac &
organ system
Stunning
Limits Use of
Cardioprotective
Medicines
AdvancingDialysis.org
Long Interdialytic Interval is Problematic
HOSPITALIZATIONS AND MORTALITY AFTER THE 2-DAY “KILLER GAP”1
• The long interdialytic interval, commonly
referred to as the 2-day “Killer Gap,” is a time
of heightened risk of mortality and morbidity
with conventional hemodialysis.1
• Rates of death and cardiovascular
hospitalization were 23% and 124% higher
after the gap, respectively, than on other days.1
FIGURE:
Rates of death and cardiovascular hospitalization on the day after
the 2-day gap in dialysis treatment and on all others days.1
1Foley, R. N., Gilbertson, D. T., Murray, T., & Collins, A. J. (2011). Long interdialytic interval and mortality
among patients receiving hemodialysis. New England Journal of Medicine, 365(12), 1099-1107.
AdvancingDialysis.org
Increased Risk of
Sudden Cardiac Death1
• Decreased eGFR has been
suggested to cause endocardial
and diffuse myocardial fibrosis that
could increase the risk of life-
threatening ventricular arrhythmias
and sudden cardiac death (SCD)2
• Each 10 mL/min/1.73 m2 decline in
eGFR has been associated with an
11% increased risk of SCD1
General
population
1.5
CVD, GFR >60
3.8
CKD stage III, IV
7.3
CKD stage V,
non-dialysis
12.6
Dialysis
24.2
0 5 10 15 20 25 30
EVENTS PER 1000 PATIENT YEARS
RATES OF SUDDEN CARDIAC DEATH IN
SELECTED POPULATIONS1,3
1Pun, P.H. et al. Chronic kidney disease is associated with
increased risk of sudden cardiac death among patients with
coronary artery disease. Kidney International (2009) 76, 652–658.
2Mark PB, Johnston N, Groenning BA et al. Redefinition of uremic
cardiomyopathy by contrast-enhanced cardiac magnetic
resonance imaging. Kidney Int 2006; 69: 1839–1845.
3Hayashi M., Shimizu W., Albert C.M. The Spectrum of
Epidemiology Underlying Sudden Cardiac Death. Circulation
Research. 2015;116:1887-1906
AdvancingDialysis.org
• Incidence rate of clinically
significant arrhythmias was
4.5 events per patient-month
(1,678 events)
‒ Leading arrhythmia was
bradycardia
• 3.9 events per patient-
month
‒ Significantly lower rate of
ventricular tachycardia or
asystole
1Roy-Chaudhury, P., et al. Primary outcomes of the Monitoring in
Dialysis Study indicate that clinically significant arrhythmias are common
in hemodialysis patients and related to dialytic cycle. Kidney Int.
2018;93:941–951.
2/3 Patients Experienced
Clinically Significant Arrhythmias1
AdvancingDialysis.org
97% Patients Experienced
Confirmed Arrhythmias1
• Incidence rate of arrhythmias not
meeting definition of clinically significant
arrhythmias (CSA) were
33.74 events per patient-month
(12,480 events)
‒ Leading arrhythmias were atrial
and sinus tachycardia
‒ Significantly lower rate of
ventricular tachycardia or
asystole; similar to CSA findings
1Roy-Chaudhury, P., et al. Primary outcomes of the Monitoring in
Dialysis Study indicate that clinically significant arrhythmias are
common in hemodialysis patients and related to dialytic cycle. Kidney
Int. 2018;93:941–951.
AdvancingDialysis.org
Ultrafiltration Rates over 6mL/kg/hr.
Associated with Increased Risk of Death
AGGRESSIVE FLUID REMOVAL RATES AND ALL-CAUSE MORTALITY
METHODS:
118,394 hemodialysis
patients in DaVita facilities,
2008-2012, with mean
follow-up of 2.3 years. Mean
UF rate was characterized
during a 30-day baseline
interval.1
Fine and Gray proportional
sub-distribution hazards
regression models with
kidney transplantation and
dialysis modality change
treated as competing risks
were used to estimate the
ultrafiltration rate and all-
cause mortality association.1
1Assimon, M.M. et al. Ultrafiltration Rate and Mortality in Maintenance Hemodialysis Patients. Am J Kidney Dis.
2016;68(6):911-922
1.00 1.03
1.09
1.15
1.23
1.43
0.80
1.00
1.20
1.40
1.60
<6 6 to 8 8 to 10 10 to 12 12 to 14 >14
Rate of fluid removal from the patient -- mL/kg/hr
RiskofDeath(HR)
AdvancingDialysis.org
Chronic Fluid Overload Adds Mortality Risk
ACROSS ALL BLOOD PRESSURE STRATA1
1Zoccali et al. Chronic Fluid Overload and Mortality in ESRD. J Am Soc Nephrol. 2017 Aug;28(8):2491-2497
Figure 4.
1-year cumulative Fluid
Overload (FO) and mortality in
patients stratified by predialysis
systolic BP. Data are adjusted.
Fluid-overloaded patients had a
significantly higher risk of death
compared with non-overloaded
patients across all BP strata (all
P<0.001).1
4.8 Kg above dry ECF
0.9 Kg above dry ECF
AdvancingDialysis.org
Class Patient Symptoms
Class I (mild) No limitation of physical activity. Ordinary physical activity does not
cause undue fatigue, palpitation, or dyspnea.
Class II (mild) Slight limitation of physical activity. Comfortable at rest, but ordinary
physical activity results in fatigue, palpitation, or dyspnea.
Class III (moderate) Marked limitation of physical activity. Comfortable at rest, but less than
ordinary activity causes fatigue, palpitation, or dyspnea.
Class IV (severe) Unable to carry out any physical activity without discomfort. Symptoms
of cardiac insufficiency at rest. If any physical activity is undertaken,
discomfort is increased.
Characterizations of Heart Failure
CLASSES BY SEVERITY OF SYMPTOMS
COMMONLY CITED: NEW YORK HEART ASSOCIATION FUNCTION CLASSIfiCATIONS:1
1The Criteria Committee of the New York Heart Association. Diseases of the Heart and Blood Vessels:
Nomenclature and Criteria for Diagnosis. 6th edition. Boston, MA: Little Brown, 1964.
AdvancingDialysis.org
ESRD “Reactive” Classification System
ADQI DYSPNEA ASSESSMENT
• Dyspnea pre and post hemodialysis
treatment assessment
• Class assignment assumes the
achievement of dry weight and usual
level of pre/post dyspnea
• Patients scored by their post-
treatment dyspnea assessment:
‒ If dyspnea symptoms improve to
class I levels, the patient would
be classified as class 2R
‒ If dyspnea symptoms improve to
class II levels, the patient would
be classified as class 3R.
Chawla LS, Herzog CA, Costanzo MR et al. Proposal for a Functional Classification System of Heart Failure in
Patients With End-Stage Renal Disease. J Am Coll Cardiol 2014;63:1246–52
AdvancingDialysis.org
NKF-KDOQI
HEMODIALYSIS ADEQUACY GUIDELINE: 2015 UPDATE
Consider additional hemodialysis sessions or longer
hemodialysis treatment times for patients with:
• Large weight gains
• High ultrafiltration rates
• Poorly controlled blood pressure
• Difficulty achieving dry weight
• Poor metabolic control (such as hyperphosphatemia,
metabolic acidosis, and/or hyperkalemia)
• Inadequate sodium/water removal to manage
hypertension, hypervolemia, and left ventricular
hypertrophy
National Kidney Foundation. KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update. Am
J Kidney Dis. 2015;66(5):884-930.
AdvancingDialysis.org
Home Dialysis Utilization
INCREASE IN NUMBER OF HOME DIALYSIS PATIENTS
*USRDS 2017 ADR Reference Table D.1: Percentages & counts of reported ESRD patients: by treatment
modality
28,317 28,955
36,083
46,772
51,057
2,081
4,378
7,049 8,523 8,987
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
US HOME DIALYSIS
PATIENTS
Peritoneal Dialysis Home hemodialysis
HOME DIALYSIS UTILIZATION:
REMAINS <12% OF PATIENTS
AdvancingDialysis.org
Addressing Consistent Volume Control
INCREASED TREATMENT TIME AND FREQUENCY
*See references on slides 28-30
Clinical Considerations for Number of
Hemodialysis Treatments per Week:*
3 Tx 3.5 – 4 Tx 5+ Tx
(“Daily”)
5+ Tx
(“Nocturnal”)
• Longer hemodialysis
treatment time (ex.
nocturnal treatments)
has improved mortality
in observational studies1
• Could mitigate the 2-day
killer gap2
• Possibility to decrease
UFR with 2-3 additional
hours of time per
treatment3,4
• Improved BP control &
survival1,4-8
• Reduced LVH &
cardiovascular
hospitalizations4,7,8,10
• Reduced UFR, recovery
time & hypotensive
episodes3-5,10-15
• Improvements in sleep
quality, RLS &
HRQoL5,16-18
• Limits volume loading
between treatments
Benefits from 5+ days per
week plus:
• Improved sleep and
obstructive sleep
apnea14,17
• Best dialytic PO4
control4,20,21
• Increased reduction in
post dialysis recovery
time15
AdvancingDialysis.org
Broader context as summarized by Dr. Allan J. Collins:
Trends in the US Dialysis population:
• Rate of growth of the US dialysis has slowed to less than 2% per year
• Progress on reducing death rates has not only slowed, but stagnated from 2014 to 2016
• US hospitalization rates flattened with expanding use of emergency room visits and
observation stays is a new, major concern
• Cardiovascular disease and infection remain the leading causes of hospital visits with little
progress in recent years
• Long weekend, interdialytic interval is a risk for death and hospitalization on the first run of
the week
• How are these populations going to be managed to reduce morbidity, mortality and cost
over the coming decade with shortages of physicians, nurses and inflationary costs?
Dr. Collins has held several leadership roles at the National Kidney Foundation (NKF), serving as
president for two years, and on the NKF scientific advisory board for six years, and with the Kidney
Dialysis Outcomes Quality Initiative. Dr. Collins is the Chief Medical Officer for NxStage Medical, Inc.
AdvancingDialysis.org
Critical, unmet needs in current dialysis patient care:
‒ Chronic fluid overload
‒ Aggressive ultrafiltration rates
‒ Recovery time
‒ Cardiovascular-related hospitalizations and death
• Reactive classifications and care pose challenges to adequate interventions to treat heart
disease and cardiovascular complications
• Multiple randomized clinical trials and large observational cohort studies have shown
hemodialysis that 5 or 6 sessions per week can positively address heart disease
• Proactive disease management should be our aim for current and future patients entrusted to
our care
Dr. Collins has held several leadership roles at the National Kidney Foundation (NKF), serving as
president for two years, and on the NKF scientific advisory board for six years, and with the Kidney
Dialysis Outcomes Quality Initiative. Dr. Collins is the Chief Medical Officer for NxStage Medical, Inc.
AdvancingDialysis.org
Proactive for either secondary or primary prevention of cardiovascular
disease:
• Transplant candidates 
‒ Poor control of CVD and BMD while on waitlist could be alleviated with more frequent treatments
• Pregnant patients 
‒ Physiologic volume-loaded state is best treated with more frequent hemodialysis
‒ Long-term health of the mother should be a rationale for more frequent and longer treatments
• Sleep apnea patients 
‒ Likely represents a volume loaded state with central edema, hypoxia and pulmonary
hypertension with right heart overload
‒ Could be mitigated with more frequent or nocturnal hemodialysis
• Restless leg syndrome patients 
‒ Likely represents persistent uremia toxins nervous system toxicity which is treated with more
frequent hemodialysis
• Hyper oxalosis patients 
‒ Best treated with maximum long nocturnal, daily hemodialysis therapy
AdvancingDialysis.org
About this presentation
This presentation is one in an ongoing series focused on recent articles, clinical findings or
guidelines related to issues affecting dialysis patients.
AdvancingDialysis.org is dedicated to providing clinicians and patients with better access to
and more awareness of the reported clinical benefits and improved quality of life made
possible with home dialysis, including solo and nocturnal therapy schedules.
For more information, visit AdvancingDialysis.org
AdvancingDialysis.org is a project of NxStage Medical, Inc.
AdvancingDialysis.org
Risks and Responsibilities
Not everyone will experience the reported benefits of home and more frequent
hemodialysis. All forms of hemodialysis involve some risks. When vascular access is
exposed to more frequent use, infection of the site, and other access related complications
may also be potential risks.
Certain risks associated with hemodialysis treatment are increased when performing solo
home hemodialysis because no one is present to help the patient respond to health
emergencies.
Certain risks associated with hemodialysis treatment are increased when performing
nocturnal therapy due to the length of treatment time and because the patient and care
partner are sleeping.
AdvancingDialysis.org
Clinical Evidence for Benefits Of Increased
Frequency at Home
REFERENCES
1Rivara MB et al. Extended-hours hemodialysis is associated with lower mortality risk in patients with end-stage renal
disease. Kidney Int. 2016 Dec;90(6):1312-1320.
2Foley, R. N., Gilbertson, D. T., Murray, T., Collins, A. J. Long interdialytic interval and mortality among patients receiving
hemodialysis. NEJM. 2011;365(12):1099-1107.
3Raimann, J.G., et al. The Effect of Increased Frequency of Hemodialysis on Volume-Related Outcomes: A Secondary
Analysis of the Frequent Hemodialysis Network Trials. Blood Purif 2016;41:277–286.
4FHN Trial Group, Chertow, G.M., Levin, N.W., Beck, G.J. et al. In-center hemodialysis six times per week versus three times
per week. N Engl J Med. 2010; 363: 2287–2300.
5Morfin, J.A., Fluck, R.J., Weinhandl, E.D., Kansal, S., McCullough, P.A., and Komenda, P. Intensive hemodialysis and
treatment complications and tolerability. Am J Kidney Dis. 2016; 68: S43–S50.
6Bakris, G.L., Burkart, J.M., Weinhandl, E.D., McCullough, P.A., and Kraus, M.A. Intensive hemodialysis, blood pressure, and
antihypertensive medication use. Am J Kidney Dis. 2016; 68: S15–S23.
7Weinhandl ED, Gilbertson DT, Collins AJ. Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and
Matched Peritoneal Dialysis Patients: A Matched Cohort Study. Am J Kidney Dis. 2016;67(1):98-110.
8Weinhandl, E.D., Liu, J., Gilbertson, D.T., Arneson, T.J., Collins, A.J. Survival in daily home hemodialysis and matched thrice-
weekly in-center hemodialysis patients. J Am Soc Nephrol. 2012;23:895–904.
9Chan, C.T., Greene, T., Chertow, G.M. et al. Determinants of left ventricular mass in patients on hemodialysis: Frequent
Hemodialysis Network (FHN) Trials. Circ Cardiovasc Imaging. 2012; 5: 251–261.
AdvancingDialysis.org
10McCullough, P.A., Chan, C.T., Weinhandl, E.D., Burkart, J.M., and Bakris, G.L. Intensive hemodialysis, left ventricular
hypertrophy, and cardiovascular disease. Am J Kidney Dis. 2016; 68: S5–S14.
11Weinhandl, Collins, Kraus. Ultrafiltration Rates with More Frequent Home Hemodialysis. Oral Presentation. 2017 ADC.
12Stefánsson, B.V., Brunelli, S.M., Cabrera, C. et al. Intradialytic hypotension and risk of cardiovascular disease. Clin J Am
Soc Nephrol. 2014; 9: 2124–2132.
13Jefferies, H.J., et al. Frequent Hemodialysis Schedules Are Associated with Reduced Levels of Dialysis-induced Cardiac
Injury (Myocardial Stunning). Clin J Am Soc Nephrol. 2011 June; 6(6): 1326–1332.
14Jaber BL, Lee Y, Collins AJ, et al. Effect of daily hemodialysis on depressive symptoms and postdialysis recovery time:
interim report from the FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements)
Study. Am J Kidney Dis. 2010;56(3):531-539.
15Lindsay RM, Heidenheim PA, Nesrallah G, Garg AX, Suri R, Daily Hemodialysis Study Group London Health Sciences
Centre. Minutes to recovery after a hemodialysis session: a simple health-related quality of life question that is reliable, valid,
and sensitive to change. CJASN. 2006;1(5):952-959.
16Jaber BL, et al. Impact of Short Daily Hemodialysis on Restless Legs Symptoms and Sleep Disturbances. CJASN May 2011
vol. 6 no. 5 1049-1056.
17Finkelstien FO, et al. At-home short daily hemodialysis improves the long-term health-related quality of life. Kidney
International (2012) 82, 561–569.
18Kraus, Michael A. et al. Intensive Hemodialysis and Health-Related Quality of Life. Am J of Kidney Dis. 2016;68:S33-S42.
Clinical Evidence for Benefits Of Increased
Frequency at Home
REFERENCES
AdvancingDialysis.org
19Hanley, P.J., Pierratos, A. Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal
hemodialysis. N Engl J Med: 2001; Vol. 344, No. 2.
20Daugirdas JT, Chertow GM, Larive B, et al. Effects of frequent hemodialysis on measures of CKD mineral and bone
disorder. JASN. 2012;23(4):727-738.
21Copland, M. et al. Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use. Am J Kid D: 2016;
Volume 68, Issue 5, Supplement 1, Pages S24–S32.
Clinical Evidence for Benefits Of Increased
Frequency at Home
REFERENCES
AdvancingDialysis.org
www.AdvancingDialysis.org
© 2018 NxStage Medical, Inc.

More Related Content

What's hot

Advancing dialysis - Improving Outcomes for Dialysis Patients
Advancing dialysis - Improving Outcomes for Dialysis PatientsAdvancing dialysis - Improving Outcomes for Dialysis Patients
Advancing dialysis - Improving Outcomes for Dialysis Patientsnxstage
 
Advancing Dialysis - Cardiovascular Disease
Advancing Dialysis - Cardiovascular DiseaseAdvancing Dialysis - Cardiovascular Disease
Advancing Dialysis - Cardiovascular DiseaseAdvancingDialysis.org
 
Advancing Dialysis - Symptoms During Dialysis
Advancing Dialysis - Symptoms During DialysisAdvancing Dialysis - Symptoms During Dialysis
Advancing Dialysis - Symptoms During DialysisAdvancingDialysis.org
 
Anticoagulation in chronic kidney disease dr. mohsen el kossi
Anticoagulation in chronic kidney disease dr. mohsen el kossiAnticoagulation in chronic kidney disease dr. mohsen el kossi
Anticoagulation in chronic kidney disease dr. mohsen el kossiFarragBahbah
 
Early goal-directed therapy in severe sepsis and septic shock: ProCESS, ARISE...
Early goal-directed therapy in severe sepsis and septic shock: ProCESS, ARISE...Early goal-directed therapy in severe sepsis and septic shock: ProCESS, ARISE...
Early goal-directed therapy in severe sepsis and septic shock: ProCESS, ARISE...Moh'd sharshir
 
Advancing Dialysis - Symptoms During Dialysis
Advancing Dialysis - Symptoms During DialysisAdvancing Dialysis - Symptoms During Dialysis
Advancing Dialysis - Symptoms During Dialysisnxstage
 
Patient under dialysis with uncontrolled hypertension
Patient under dialysis with uncontrolled hypertension Patient under dialysis with uncontrolled hypertension
Patient under dialysis with uncontrolled hypertension Haytham Ghareeb
 
Advancing Dialysis - Intensive Hemodialysis
Advancing Dialysis - Intensive HemodialysisAdvancing Dialysis - Intensive Hemodialysis
Advancing Dialysis - Intensive Hemodialysisnxstage
 
Hemodialysis.com | Kidney Disease | ESRD | Dialysis
Hemodialysis.com | Kidney Disease | ESRD | DialysisHemodialysis.com | Kidney Disease | ESRD | Dialysis
Hemodialysis.com | Kidney Disease | ESRD | DialysisMarie Benz MD FAAD
 
Steroid Sparing Regimens in Kidney Transplantation
Steroid Sparing Regimens in Kidney TransplantationSteroid Sparing Regimens in Kidney Transplantation
Steroid Sparing Regimens in Kidney TransplantationAbdullah Ansari
 
ICN VIctoria: John Botha on Critical Care Renal Failure
ICN VIctoria: John Botha on Critical Care Renal FailureICN VIctoria: John Botha on Critical Care Renal Failure
ICN VIctoria: John Botha on Critical Care Renal FailureGerard Fennessy
 
Acute Heart Failure – The road to where
Acute Heart Failure – The road to whereAcute Heart Failure – The road to where
Acute Heart Failure – The road to wheredrucsamal
 
Sarnak2019
Sarnak2019Sarnak2019
Sarnak2019nazmi287
 
Early Goal-Directed Therapy in Septic Shock
Early Goal-Directed Therapy in Septic ShockEarly Goal-Directed Therapy in Septic Shock
Early Goal-Directed Therapy in Septic Shockshivabirdi
 
Impact of statins and beta-blocker therapy on mortality after coronary artery...
Impact of statins and beta-blocker therapy on mortality after coronary artery...Impact of statins and beta-blocker therapy on mortality after coronary artery...
Impact of statins and beta-blocker therapy on mortality after coronary artery...Paul Schoenhagen
 
Intensive Hemodialysis, Left Ventricular Hypertrophy and Cardiovascular Disease
Intensive Hemodialysis, Left Ventricular Hypertrophy and Cardiovascular DiseaseIntensive Hemodialysis, Left Ventricular Hypertrophy and Cardiovascular Disease
Intensive Hemodialysis, Left Ventricular Hypertrophy and Cardiovascular DiseaseAdvancingDialysis.org
 
Sepsis and early goal directed therapy
Sepsis and early goal directed therapySepsis and early goal directed therapy
Sepsis and early goal directed therapyFaez Toushiro
 

What's hot (20)

Advancing dialysis - Improving Outcomes for Dialysis Patients
Advancing dialysis - Improving Outcomes for Dialysis PatientsAdvancing dialysis - Improving Outcomes for Dialysis Patients
Advancing dialysis - Improving Outcomes for Dialysis Patients
 
Advancing Dialysis - Cardiovascular Disease
Advancing Dialysis - Cardiovascular DiseaseAdvancing Dialysis - Cardiovascular Disease
Advancing Dialysis - Cardiovascular Disease
 
Sprint 2015 nejm
Sprint 2015 nejmSprint 2015 nejm
Sprint 2015 nejm
 
Advancing Dialysis - Symptoms During Dialysis
Advancing Dialysis - Symptoms During DialysisAdvancing Dialysis - Symptoms During Dialysis
Advancing Dialysis - Symptoms During Dialysis
 
Anticoagulation in chronic kidney disease dr. mohsen el kossi
Anticoagulation in chronic kidney disease dr. mohsen el kossiAnticoagulation in chronic kidney disease dr. mohsen el kossi
Anticoagulation in chronic kidney disease dr. mohsen el kossi
 
Early goal-directed therapy in severe sepsis and septic shock: ProCESS, ARISE...
Early goal-directed therapy in severe sepsis and septic shock: ProCESS, ARISE...Early goal-directed therapy in severe sepsis and septic shock: ProCESS, ARISE...
Early goal-directed therapy in severe sepsis and septic shock: ProCESS, ARISE...
 
Advancing Dialysis - Symptoms During Dialysis
Advancing Dialysis - Symptoms During DialysisAdvancing Dialysis - Symptoms During Dialysis
Advancing Dialysis - Symptoms During Dialysis
 
Patient under dialysis with uncontrolled hypertension
Patient under dialysis with uncontrolled hypertension Patient under dialysis with uncontrolled hypertension
Patient under dialysis with uncontrolled hypertension
 
Advancing Dialysis - Intensive Hemodialysis
Advancing Dialysis - Intensive HemodialysisAdvancing Dialysis - Intensive Hemodialysis
Advancing Dialysis - Intensive Hemodialysis
 
Hemodialysis.com | Kidney Disease | ESRD | Dialysis
Hemodialysis.com | Kidney Disease | ESRD | DialysisHemodialysis.com | Kidney Disease | ESRD | Dialysis
Hemodialysis.com | Kidney Disease | ESRD | Dialysis
 
Advancing Dialysis - Hypertension
Advancing Dialysis - HypertensionAdvancing Dialysis - Hypertension
Advancing Dialysis - Hypertension
 
Steroid Sparing Regimens in Kidney Transplantation
Steroid Sparing Regimens in Kidney TransplantationSteroid Sparing Regimens in Kidney Transplantation
Steroid Sparing Regimens in Kidney Transplantation
 
ICN VIctoria: John Botha on Critical Care Renal Failure
ICN VIctoria: John Botha on Critical Care Renal FailureICN VIctoria: John Botha on Critical Care Renal Failure
ICN VIctoria: John Botha on Critical Care Renal Failure
 
Acute Heart Failure – The road to where
Acute Heart Failure – The road to whereAcute Heart Failure – The road to where
Acute Heart Failure – The road to where
 
Sarnak2019
Sarnak2019Sarnak2019
Sarnak2019
 
Incremental Dialysis
Incremental DialysisIncremental Dialysis
Incremental Dialysis
 
Early Goal-Directed Therapy in Septic Shock
Early Goal-Directed Therapy in Septic ShockEarly Goal-Directed Therapy in Septic Shock
Early Goal-Directed Therapy in Septic Shock
 
Impact of statins and beta-blocker therapy on mortality after coronary artery...
Impact of statins and beta-blocker therapy on mortality after coronary artery...Impact of statins and beta-blocker therapy on mortality after coronary artery...
Impact of statins and beta-blocker therapy on mortality after coronary artery...
 
Intensive Hemodialysis, Left Ventricular Hypertrophy and Cardiovascular Disease
Intensive Hemodialysis, Left Ventricular Hypertrophy and Cardiovascular DiseaseIntensive Hemodialysis, Left Ventricular Hypertrophy and Cardiovascular Disease
Intensive Hemodialysis, Left Ventricular Hypertrophy and Cardiovascular Disease
 
Sepsis and early goal directed therapy
Sepsis and early goal directed therapySepsis and early goal directed therapy
Sepsis and early goal directed therapy
 

Similar to Advancing dialysis: Recasting kidney failure as cardiovascular disease

AdvancingDialysis.org CMS ESRD Treatment Choices (ETC) Mandatory Payment Model
AdvancingDialysis.org CMS ESRD Treatment Choices (ETC) Mandatory Payment ModelAdvancingDialysis.org CMS ESRD Treatment Choices (ETC) Mandatory Payment Model
AdvancingDialysis.org CMS ESRD Treatment Choices (ETC) Mandatory Payment ModelAdvancingDialysis.org
 
Chronic Kidney Disease Challenges and New Solutions
Chronic Kidney Disease Challenges and New SolutionsChronic Kidney Disease Challenges and New Solutions
Chronic Kidney Disease Challenges and New SolutionsViewics
 
Empowering Healthcare Leaders: The Business Case for Language Access_10.3.14
Empowering Healthcare Leaders: The Business Case for Language Access_10.3.14Empowering Healthcare Leaders: The Business Case for Language Access_10.3.14
Empowering Healthcare Leaders: The Business Case for Language Access_10.3.14Douglas Green
 
Prof Ken Mc Donald , Associate Clinical Professor UCD/ St Vincent's
Prof Ken Mc Donald , Associate Clinical Professor UCD/ St Vincent'sProf Ken Mc Donald , Associate Clinical Professor UCD/ St Vincent's
Prof Ken Mc Donald , Associate Clinical Professor UCD/ St Vincent'sInvestnet
 
Concept of a ‘CKD Clinic’
Concept of a ‘CKD Clinic’Concept of a ‘CKD Clinic’
Concept of a ‘CKD Clinic’drsanjaymaitra
 
Blood Volume Measurement
Blood Volume Measurement Blood Volume Measurement
Blood Volume Measurement Detalo Health
 
Economic Benefits Intervension in Chronic Kidney diseases
Economic Benefits Intervension in Chronic Kidney diseasesEconomic Benefits Intervension in Chronic Kidney diseases
Economic Benefits Intervension in Chronic Kidney diseasesDr. Adnan Ahmed Bhutto
 
CIR.0000000000000921.pdf
CIR.0000000000000921.pdfCIR.0000000000000921.pdf
CIR.0000000000000921.pdfcikKahadi
 
Dr Debbie Lowe - The future of innovation in AF and stroke prevention
Dr Debbie Lowe - The future of innovation in AF and stroke preventionDr Debbie Lowe - The future of innovation in AF and stroke prevention
Dr Debbie Lowe - The future of innovation in AF and stroke preventionInnovation Agency
 
59010-128_Slides.pptx
59010-128_Slides.pptx59010-128_Slides.pptx
59010-128_Slides.pptxssuser75fd45
 
Dag Andersson - CEO Diaverum, Chronic Diseases: The Everyday Epidemic
Dag Andersson - CEO Diaverum,  Chronic Diseases: The Everyday EpidemicDag Andersson - CEO Diaverum,  Chronic Diseases: The Everyday Epidemic
Dag Andersson - CEO Diaverum, Chronic Diseases: The Everyday EpidemicMarc Michel
 
Assessment of intravascular volume status
Assessment of intravascular volume statusAssessment of intravascular volume status
Assessment of intravascular volume statusDetalo Health
 
Prevalence of cvd risk factors among qatari patients with type 2 diabetes mel...
Prevalence of cvd risk factors among qatari patients with type 2 diabetes mel...Prevalence of cvd risk factors among qatari patients with type 2 diabetes mel...
Prevalence of cvd risk factors among qatari patients with type 2 diabetes mel...Dr. Anees Alyafei
 
Running head MEDICAL CARE PLANNING FOR PATIENTS WITH CHRONIC KIDN.docx
Running head MEDICAL CARE PLANNING FOR PATIENTS WITH CHRONIC KIDN.docxRunning head MEDICAL CARE PLANNING FOR PATIENTS WITH CHRONIC KIDN.docx
Running head MEDICAL CARE PLANNING FOR PATIENTS WITH CHRONIC KIDN.docxjeanettehully
 
Acquired hemophilia a nonhematologist perspective
Acquired hemophilia a nonhematologist perspectiveAcquired hemophilia a nonhematologist perspective
Acquired hemophilia a nonhematologist perspectiveMuhammad Asim Rana
 
Esrd in elderly patients 2019 latest
Esrd in elderly patients 2019 latestEsrd in elderly patients 2019 latest
Esrd in elderly patients 2019 latestFAARRAG
 

Similar to Advancing dialysis: Recasting kidney failure as cardiovascular disease (20)

AdvancingDialysis.org CMS ESRD Treatment Choices (ETC) Mandatory Payment Model
AdvancingDialysis.org CMS ESRD Treatment Choices (ETC) Mandatory Payment ModelAdvancingDialysis.org CMS ESRD Treatment Choices (ETC) Mandatory Payment Model
AdvancingDialysis.org CMS ESRD Treatment Choices (ETC) Mandatory Payment Model
 
Chronic Kidney Disease Challenges and New Solutions
Chronic Kidney Disease Challenges and New SolutionsChronic Kidney Disease Challenges and New Solutions
Chronic Kidney Disease Challenges and New Solutions
 
Sepsis 9-2015
Sepsis  9-2015Sepsis  9-2015
Sepsis 9-2015
 
Empowering Healthcare Leaders: The Business Case for Language Access_10.3.14
Empowering Healthcare Leaders: The Business Case for Language Access_10.3.14Empowering Healthcare Leaders: The Business Case for Language Access_10.3.14
Empowering Healthcare Leaders: The Business Case for Language Access_10.3.14
 
Ckd 2016 100 1
Ckd 2016 100 1Ckd 2016 100 1
Ckd 2016 100 1
 
Prof Ken Mc Donald , Associate Clinical Professor UCD/ St Vincent's
Prof Ken Mc Donald , Associate Clinical Professor UCD/ St Vincent'sProf Ken Mc Donald , Associate Clinical Professor UCD/ St Vincent's
Prof Ken Mc Donald , Associate Clinical Professor UCD/ St Vincent's
 
Concept of a ‘CKD Clinic’
Concept of a ‘CKD Clinic’Concept of a ‘CKD Clinic’
Concept of a ‘CKD Clinic’
 
Blood Volume Measurement
Blood Volume Measurement Blood Volume Measurement
Blood Volume Measurement
 
Economic Benefits Intervension in Chronic Kidney diseases
Economic Benefits Intervension in Chronic Kidney diseasesEconomic Benefits Intervension in Chronic Kidney diseases
Economic Benefits Intervension in Chronic Kidney diseases
 
CIR.0000000000000921.pdf
CIR.0000000000000921.pdfCIR.0000000000000921.pdf
CIR.0000000000000921.pdf
 
Aging and Co-Morbidities in Persons Infected with HIV
Aging and Co-Morbidities in Persons Infected with HIVAging and Co-Morbidities in Persons Infected with HIV
Aging and Co-Morbidities in Persons Infected with HIV
 
Dr Debbie Lowe - The future of innovation in AF and stroke prevention
Dr Debbie Lowe - The future of innovation in AF and stroke preventionDr Debbie Lowe - The future of innovation in AF and stroke prevention
Dr Debbie Lowe - The future of innovation in AF and stroke prevention
 
59010-128_Slides.pptx
59010-128_Slides.pptx59010-128_Slides.pptx
59010-128_Slides.pptx
 
Dag Andersson - CEO Diaverum, Chronic Diseases: The Everyday Epidemic
Dag Andersson - CEO Diaverum,  Chronic Diseases: The Everyday EpidemicDag Andersson - CEO Diaverum,  Chronic Diseases: The Everyday Epidemic
Dag Andersson - CEO Diaverum, Chronic Diseases: The Everyday Epidemic
 
Assessment of intravascular volume status
Assessment of intravascular volume statusAssessment of intravascular volume status
Assessment of intravascular volume status
 
Prevalence of cvd risk factors among qatari patients with type 2 diabetes mel...
Prevalence of cvd risk factors among qatari patients with type 2 diabetes mel...Prevalence of cvd risk factors among qatari patients with type 2 diabetes mel...
Prevalence of cvd risk factors among qatari patients with type 2 diabetes mel...
 
Diabesity with Sharon Weinstein
Diabesity with Sharon WeinsteinDiabesity with Sharon Weinstein
Diabesity with Sharon Weinstein
 
Running head MEDICAL CARE PLANNING FOR PATIENTS WITH CHRONIC KIDN.docx
Running head MEDICAL CARE PLANNING FOR PATIENTS WITH CHRONIC KIDN.docxRunning head MEDICAL CARE PLANNING FOR PATIENTS WITH CHRONIC KIDN.docx
Running head MEDICAL CARE PLANNING FOR PATIENTS WITH CHRONIC KIDN.docx
 
Acquired hemophilia a nonhematologist perspective
Acquired hemophilia a nonhematologist perspectiveAcquired hemophilia a nonhematologist perspective
Acquired hemophilia a nonhematologist perspective
 
Esrd in elderly patients 2019 latest
Esrd in elderly patients 2019 latestEsrd in elderly patients 2019 latest
Esrd in elderly patients 2019 latest
 

Recently uploaded

Field exchange, Issue 72 April 2024 FEX-72.pdf
Field exchange, Issue 72 April 2024 FEX-72.pdfField exchange, Issue 72 April 2024 FEX-72.pdf
Field exchange, Issue 72 April 2024 FEX-72.pdfMohamed Miyir
 
Call Girls Rajendra Nagar 9999965857 Cheap and Best with original Photos
Call Girls Rajendra Nagar 9999965857 Cheap and Best with original PhotosCall Girls Rajendra Nagar 9999965857 Cheap and Best with original Photos
Call Girls Rajendra Nagar 9999965857 Cheap and Best with original Photosparshadkalavatidevi7
 
Single Assessment Framework - What We Know So Far
Single Assessment Framework - What We Know So FarSingle Assessment Framework - What We Know So Far
Single Assessment Framework - What We Know So FarCareLineLive
 
2024 HCAT Healthcare Technology Insights
2024 HCAT Healthcare Technology Insights2024 HCAT Healthcare Technology Insights
2024 HCAT Healthcare Technology InsightsHealth Catalyst
 
Call Girls Laxmi Nagar 9999965857 Cheap and Best with original Photos
Call Girls Laxmi Nagar 9999965857 Cheap and Best with original PhotosCall Girls Laxmi Nagar 9999965857 Cheap and Best with original Photos
Call Girls Laxmi Nagar 9999965857 Cheap and Best with original Photosparshadkalavatidevi7
 
Gurgaon Sector 45 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 45 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...Gurgaon Sector 45 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 45 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...vrvipin164
 
The future of change - strategic translation
The future of change - strategic translationThe future of change - strategic translation
The future of change - strategic translationHelenBevan4
 
Disaster Management Cycle (DMC)| Ms. Pooja Sharma , Department of Hospital A...
Disaster Management Cycle (DMC)| Ms. Pooja Sharma , Department of  Hospital A...Disaster Management Cycle (DMC)| Ms. Pooja Sharma , Department of  Hospital A...
Disaster Management Cycle (DMC)| Ms. Pooja Sharma , Department of Hospital A...Era University , Lucknow
 
Call Girls Delhi 9873940964 Elite Escort Service Available 24/7 Hire
Call Girls Delhi 9873940964 Elite Escort Service Available 24/7 HireCall Girls Delhi 9873940964 Elite Escort Service Available 24/7 Hire
Call Girls Delhi 9873940964 Elite Escort Service Available 24/7 HireCall Girls Delhi
 
Book Call Girls in Hosur - 7001305949 | 24x7 Service Available Near Me
Book Call Girls in Hosur - 7001305949 | 24x7 Service Available Near MeBook Call Girls in Hosur - 7001305949 | 24x7 Service Available Near Me
Book Call Girls in Hosur - 7001305949 | 24x7 Service Available Near Menarwatsonia7
 
Call Girls Hsr Layout Whatsapp 7001305949 Independent Escort Service
Call Girls Hsr Layout Whatsapp 7001305949 Independent Escort ServiceCall Girls Hsr Layout Whatsapp 7001305949 Independent Escort Service
Call Girls Hsr Layout Whatsapp 7001305949 Independent Escort Servicenarwatsonia7
 
Text Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptxText Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptxProf. Satyen Bhattacharyya
 
Call Girls Dwarka 9999965857 Cheap & Best with original Photos
Call Girls Dwarka 9999965857 Cheap & Best with original PhotosCall Girls Dwarka 9999965857 Cheap & Best with original Photos
Call Girls Dwarka 9999965857 Cheap & Best with original Photosparshadkalavatidevi7
 
Hi,Fi Call Girl In Marathahalli - 7001305949 with real photos and phone numbers
Hi,Fi Call Girl In Marathahalli - 7001305949 with real photos and phone numbersHi,Fi Call Girl In Marathahalli - 7001305949 with real photos and phone numbers
Hi,Fi Call Girl In Marathahalli - 7001305949 with real photos and phone numbersnarwatsonia7
 
Clinical Education Presentation at Accelacare
Clinical Education Presentation at AccelacareClinical Education Presentation at Accelacare
Clinical Education Presentation at Accelacarepablor40
 
TEENAGE PREGNANCY PREVENTION AND AWARENESS
TEENAGE PREGNANCY PREVENTION AND AWARENESSTEENAGE PREGNANCY PREVENTION AND AWARENESS
TEENAGE PREGNANCY PREVENTION AND AWARENESSPeterJamesVitug
 
Call Girls Service Bommasandra - Call 7001305949 Rs-3500 with A/C Room Cash o...
Call Girls Service Bommasandra - Call 7001305949 Rs-3500 with A/C Room Cash o...Call Girls Service Bommasandra - Call 7001305949 Rs-3500 with A/C Room Cash o...
Call Girls Service Bommasandra - Call 7001305949 Rs-3500 with A/C Room Cash o...narwatsonia7
 
Gurgaon DLF Phase 5 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Fe...
Gurgaon DLF Phase 5 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Fe...Gurgaon DLF Phase 5 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Fe...
Gurgaon DLF Phase 5 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Fe...ggsonu500
 
FAMILY in sociology for physiotherapists.pptx
FAMILY in sociology for physiotherapists.pptxFAMILY in sociology for physiotherapists.pptx
FAMILY in sociology for physiotherapists.pptxMumux Mirani
 
Gurgaon Sector 72 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 72 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...Gurgaon Sector 72 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 72 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...stina6279
 

Recently uploaded (20)

Field exchange, Issue 72 April 2024 FEX-72.pdf
Field exchange, Issue 72 April 2024 FEX-72.pdfField exchange, Issue 72 April 2024 FEX-72.pdf
Field exchange, Issue 72 April 2024 FEX-72.pdf
 
Call Girls Rajendra Nagar 9999965857 Cheap and Best with original Photos
Call Girls Rajendra Nagar 9999965857 Cheap and Best with original PhotosCall Girls Rajendra Nagar 9999965857 Cheap and Best with original Photos
Call Girls Rajendra Nagar 9999965857 Cheap and Best with original Photos
 
Single Assessment Framework - What We Know So Far
Single Assessment Framework - What We Know So FarSingle Assessment Framework - What We Know So Far
Single Assessment Framework - What We Know So Far
 
2024 HCAT Healthcare Technology Insights
2024 HCAT Healthcare Technology Insights2024 HCAT Healthcare Technology Insights
2024 HCAT Healthcare Technology Insights
 
Call Girls Laxmi Nagar 9999965857 Cheap and Best with original Photos
Call Girls Laxmi Nagar 9999965857 Cheap and Best with original PhotosCall Girls Laxmi Nagar 9999965857 Cheap and Best with original Photos
Call Girls Laxmi Nagar 9999965857 Cheap and Best with original Photos
 
Gurgaon Sector 45 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 45 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...Gurgaon Sector 45 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 45 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
 
The future of change - strategic translation
The future of change - strategic translationThe future of change - strategic translation
The future of change - strategic translation
 
Disaster Management Cycle (DMC)| Ms. Pooja Sharma , Department of Hospital A...
Disaster Management Cycle (DMC)| Ms. Pooja Sharma , Department of  Hospital A...Disaster Management Cycle (DMC)| Ms. Pooja Sharma , Department of  Hospital A...
Disaster Management Cycle (DMC)| Ms. Pooja Sharma , Department of Hospital A...
 
Call Girls Delhi 9873940964 Elite Escort Service Available 24/7 Hire
Call Girls Delhi 9873940964 Elite Escort Service Available 24/7 HireCall Girls Delhi 9873940964 Elite Escort Service Available 24/7 Hire
Call Girls Delhi 9873940964 Elite Escort Service Available 24/7 Hire
 
Book Call Girls in Hosur - 7001305949 | 24x7 Service Available Near Me
Book Call Girls in Hosur - 7001305949 | 24x7 Service Available Near MeBook Call Girls in Hosur - 7001305949 | 24x7 Service Available Near Me
Book Call Girls in Hosur - 7001305949 | 24x7 Service Available Near Me
 
Call Girls Hsr Layout Whatsapp 7001305949 Independent Escort Service
Call Girls Hsr Layout Whatsapp 7001305949 Independent Escort ServiceCall Girls Hsr Layout Whatsapp 7001305949 Independent Escort Service
Call Girls Hsr Layout Whatsapp 7001305949 Independent Escort Service
 
Text Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptxText Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptx
 
Call Girls Dwarka 9999965857 Cheap & Best with original Photos
Call Girls Dwarka 9999965857 Cheap & Best with original PhotosCall Girls Dwarka 9999965857 Cheap & Best with original Photos
Call Girls Dwarka 9999965857 Cheap & Best with original Photos
 
Hi,Fi Call Girl In Marathahalli - 7001305949 with real photos and phone numbers
Hi,Fi Call Girl In Marathahalli - 7001305949 with real photos and phone numbersHi,Fi Call Girl In Marathahalli - 7001305949 with real photos and phone numbers
Hi,Fi Call Girl In Marathahalli - 7001305949 with real photos and phone numbers
 
Clinical Education Presentation at Accelacare
Clinical Education Presentation at AccelacareClinical Education Presentation at Accelacare
Clinical Education Presentation at Accelacare
 
TEENAGE PREGNANCY PREVENTION AND AWARENESS
TEENAGE PREGNANCY PREVENTION AND AWARENESSTEENAGE PREGNANCY PREVENTION AND AWARENESS
TEENAGE PREGNANCY PREVENTION AND AWARENESS
 
Call Girls Service Bommasandra - Call 7001305949 Rs-3500 with A/C Room Cash o...
Call Girls Service Bommasandra - Call 7001305949 Rs-3500 with A/C Room Cash o...Call Girls Service Bommasandra - Call 7001305949 Rs-3500 with A/C Room Cash o...
Call Girls Service Bommasandra - Call 7001305949 Rs-3500 with A/C Room Cash o...
 
Gurgaon DLF Phase 5 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Fe...
Gurgaon DLF Phase 5 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Fe...Gurgaon DLF Phase 5 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Fe...
Gurgaon DLF Phase 5 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Fe...
 
FAMILY in sociology for physiotherapists.pptx
FAMILY in sociology for physiotherapists.pptxFAMILY in sociology for physiotherapists.pptx
FAMILY in sociology for physiotherapists.pptx
 
Gurgaon Sector 72 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 72 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...Gurgaon Sector 72 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 72 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
 

Advancing dialysis: Recasting kidney failure as cardiovascular disease

  • 1. AdvancingDialysis.org Recasting Kidney Failure are Cardiovascular Disease A STATE OF PERSISTENT FLUID OVERLOAD
  • 2. AdvancingDialysis.org ESRD: Represents 7% of the Medicare Budget TREATS ONLY 1% OF THE US POPULATION1 • The rising number and costs of the dialysis population continues to attract policy makers attention. ‒ Policy makers including, the US Government Accountability Office, suggest home therapies should be expanded and barriers addresses • The challenge with increasing the use of home therapies centers on the type of the dialysis modality used, how they are applied and the barriers to utilization • The modalities need to address the chronic diseases which are major drivers of morbidity and mortality as compared to “uremia” • How home dialysis modalities address these chronic diseases and how patients feel on therapy is the ongoing challenge to moving more patients to the home setting while improving efficacy of therapy 1USRDS 2018 Vol 2 Figure 9.2: Trends in (a) total Medicare & ESRD fee-for-service spending ($, in billions), and (b) ESRD spending as percentage of Medicare fee-for-service spending, 2004-2016
  • 3. AdvancingDialysis.org $19.9 Billion $25.4 Billion $29.2 Billion $31.3 Billion $32.9 Billion $35.4 Billion 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 US DOLLARS Inpatient Outpatient Physician/supplier Part D Drugs Total Medicare Healthcare Expenditures for Dialysis Patients USRDS 2005 & 2018 Ref Table K.1: Total Medicare spending ($) of reported ESRD patients by claim type STEADILY HAS RISEN TO MORE THAN $35 BILLION/YEAR
  • 4. AdvancingDialysis.org Medicare per Capita Expenditures have Stabilized USRDS 2018 Ref Table K.6 & USRDS 2005 Ref Table K.5: Per person per year spending ($): dialysis patients, with unknown modalities dropped (model 1); period prevalent patients, as-treated model, primary payer only, by age, sex, race, ethnicity & primary diagnosis. 2005:as-treated model, Medicare primary payor only $68,020 $80,099 $85,845 $89,689 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 MEDICARE DIALYSIS EXPENDITURE PER PERSON SPEND PER PATIENT: RELATIVELY FLAT SINCE 2009
  • 5. AdvancingDialysis.org Dialysis Patient Population Increasing 2016 POPULATION: OVER 500,000+ USRDS 2018 Ref Table D.1: Percentages & counts of reported ESRD patients: by treatment modality incident & December 31 point prevalent patients 343,015 382,976 414,503 443,649 478,681 509,014 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 US DIALYSIS PATIENTS All Dialysis INCREASED SPEND DRIVEN BY INCREASED PATIENT CENSUS
  • 6. AdvancingDialysis.org Dialysis Patient Population Growth SLOWING GROWTH RATE USRDS 2018 Ref Table D.1: Percentages & counts of reported ESRD patients: by treatment modality incident & December 31 point prevalent patients 3.7% 3.2% 3.8% 4.5% 4.4% 4.3% 3.8% 3.3% 2.4% 1.8% 3.7% 3.6% 3.3% 3.0% 3.0% 2.9% 3.0% 3.2% 3.4% 3.8% 2011-1 2011-2 2011-3 2011-4 2012-1 2012-2 2012-3 2012-4 2013-1 2013-2 2013-3 2013-4 2014-1 2014-2 2014-3 2014-4 2015-1 2015-2 2015-3 2015-4 2016-1 2016-2 2016-3 2016-4 2017-1 2017-2 2017-3 2017-4 ANNUALIZED POPULATION GROWTH RATE (%) Dialysis only Transplant only GROWTH RATE: FALLEN TO BELOW 2%
  • 7. AdvancingDialysis.org 218.5 212.8 204.2 196.2 191.2 184.5 180.4 172.6 169.2 167.4 168.2 166.3 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 ANNUAL MORTALITY RATE PER 1,000 PATIENT YEARS Hemodialysis Peritoneal Dialysis Annual Mortality DIALYSIS DEATH RATES HAVE STABILIZED USRDS 2018 Ref Tables H8 & H9: Annual mortality rates: Hemodialysis & CAPD/CCPD patients, adjusted for age, sex, race, ethnicity, primary cause of ESRD, and patient vintage per 1,000 patient years at risk; period prevalent patients, by age, sex, race, ethnicity, primary cause of ESRD, & patient vintage HEMODIALYSIS DEATH RATE: RELATIVELY FLAT SINCE 2013
  • 8. AdvancingDialysis.org Hospitalizations and Hospital Days DIALYSIS HOSPITALIZATIONS HAVE STABILIZED USRDS 2018 Ref Tables G2 & G7: Total admission rates: dialysis patients per 1,000 patient years, period prevalent patients, by age, sex, race, ethnicity, primary diagnosis, & patient vintage; Hospital days: dialysis patients per patient year, period prevalent patients, by age, sex, race, ethnicity, primary diagnosis, & patient vintage. 2.1 2.1 2.0 2.0 2.0 2.0 1.9 1.9 1.8 1.7 1.7 1.7 14.5 14.4 14.0 13.5 13.2 12.7 12.5 12.0 11.6 11.4 11.4 11.3 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 HOSPITALIZATION DAYS PER PATIENT YEAR HOSPITALIZATIONS PER YEAR Hospitalizations per year Hospital days per Patient Year HOSPITALIZATIONS AND DAYS: RELATIVELY FLAT SINCE 2013
  • 9. AdvancingDialysis.org Dialysis Patient Hospitalization Utilization TRENDS SHOWING INCREASED USE OF EMERGENT CARE1,2 1Mean percentage of Medicare dialysis patients with ≥1 ER/OBS admission each week; 2014 – 2016 2Mean percentage of Medicare dialysis patients with ≥1 hospital admission each week; 2014 – 2016 MEDICARE DIALYSIS PATIENT HOSPITALIZATIONS HAVE STABILIZED2 EQUIVALENT UTILIZATION OF EMERGENCY AND OBSERVATIONAL ROOM CARE1
  • 10. AdvancingDialysis.org Management of Chronic Hypertension, Left Ventricular Hypertrophy and Heart Failure THE FATAL FLAW OF CONVENTIONAL DIALYSIS
  • 11. AdvancingDialysis.org Unmet Need in the Causal Path of Heart Disease CHRONIC FLUID OVERLOAD 1Rocco MV, Burkart JM. Prevalence of missed treatments and early sign-offs in hemodialysis patients. J Am Soc Nephrol. 1993 Nov;4(5):1178-83. Fluid Overload Uncontrolled Hypertension Left Ventricular Hypertrophy Heart Failure Hospitalization and Death Early Sign-Offs and No-Shows1 High Ultrafiltration Rate Intradialytic Hypotension Cramping, Dizziness, Nausea, etc. Long Post- Dialysis Recovery Time Poor HRQoL Cardiac & organ system Stunning Limits Use of Cardioprotective Medicines
  • 12. AdvancingDialysis.org Long Interdialytic Interval is Problematic HOSPITALIZATIONS AND MORTALITY AFTER THE 2-DAY “KILLER GAP”1 • The long interdialytic interval, commonly referred to as the 2-day “Killer Gap,” is a time of heightened risk of mortality and morbidity with conventional hemodialysis.1 • Rates of death and cardiovascular hospitalization were 23% and 124% higher after the gap, respectively, than on other days.1 FIGURE: Rates of death and cardiovascular hospitalization on the day after the 2-day gap in dialysis treatment and on all others days.1 1Foley, R. N., Gilbertson, D. T., Murray, T., & Collins, A. J. (2011). Long interdialytic interval and mortality among patients receiving hemodialysis. New England Journal of Medicine, 365(12), 1099-1107.
  • 13. AdvancingDialysis.org Increased Risk of Sudden Cardiac Death1 • Decreased eGFR has been suggested to cause endocardial and diffuse myocardial fibrosis that could increase the risk of life- threatening ventricular arrhythmias and sudden cardiac death (SCD)2 • Each 10 mL/min/1.73 m2 decline in eGFR has been associated with an 11% increased risk of SCD1 General population 1.5 CVD, GFR >60 3.8 CKD stage III, IV 7.3 CKD stage V, non-dialysis 12.6 Dialysis 24.2 0 5 10 15 20 25 30 EVENTS PER 1000 PATIENT YEARS RATES OF SUDDEN CARDIAC DEATH IN SELECTED POPULATIONS1,3 1Pun, P.H. et al. Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease. Kidney International (2009) 76, 652–658. 2Mark PB, Johnston N, Groenning BA et al. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney Int 2006; 69: 1839–1845. 3Hayashi M., Shimizu W., Albert C.M. The Spectrum of Epidemiology Underlying Sudden Cardiac Death. Circulation Research. 2015;116:1887-1906
  • 14. AdvancingDialysis.org • Incidence rate of clinically significant arrhythmias was 4.5 events per patient-month (1,678 events) ‒ Leading arrhythmia was bradycardia • 3.9 events per patient- month ‒ Significantly lower rate of ventricular tachycardia or asystole 1Roy-Chaudhury, P., et al. Primary outcomes of the Monitoring in Dialysis Study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle. Kidney Int. 2018;93:941–951. 2/3 Patients Experienced Clinically Significant Arrhythmias1
  • 15. AdvancingDialysis.org 97% Patients Experienced Confirmed Arrhythmias1 • Incidence rate of arrhythmias not meeting definition of clinically significant arrhythmias (CSA) were 33.74 events per patient-month (12,480 events) ‒ Leading arrhythmias were atrial and sinus tachycardia ‒ Significantly lower rate of ventricular tachycardia or asystole; similar to CSA findings 1Roy-Chaudhury, P., et al. Primary outcomes of the Monitoring in Dialysis Study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle. Kidney Int. 2018;93:941–951.
  • 16. AdvancingDialysis.org Ultrafiltration Rates over 6mL/kg/hr. Associated with Increased Risk of Death AGGRESSIVE FLUID REMOVAL RATES AND ALL-CAUSE MORTALITY METHODS: 118,394 hemodialysis patients in DaVita facilities, 2008-2012, with mean follow-up of 2.3 years. Mean UF rate was characterized during a 30-day baseline interval.1 Fine and Gray proportional sub-distribution hazards regression models with kidney transplantation and dialysis modality change treated as competing risks were used to estimate the ultrafiltration rate and all- cause mortality association.1 1Assimon, M.M. et al. Ultrafiltration Rate and Mortality in Maintenance Hemodialysis Patients. Am J Kidney Dis. 2016;68(6):911-922 1.00 1.03 1.09 1.15 1.23 1.43 0.80 1.00 1.20 1.40 1.60 <6 6 to 8 8 to 10 10 to 12 12 to 14 >14 Rate of fluid removal from the patient -- mL/kg/hr RiskofDeath(HR)
  • 17. AdvancingDialysis.org Chronic Fluid Overload Adds Mortality Risk ACROSS ALL BLOOD PRESSURE STRATA1 1Zoccali et al. Chronic Fluid Overload and Mortality in ESRD. J Am Soc Nephrol. 2017 Aug;28(8):2491-2497 Figure 4. 1-year cumulative Fluid Overload (FO) and mortality in patients stratified by predialysis systolic BP. Data are adjusted. Fluid-overloaded patients had a significantly higher risk of death compared with non-overloaded patients across all BP strata (all P<0.001).1 4.8 Kg above dry ECF 0.9 Kg above dry ECF
  • 18. AdvancingDialysis.org Class Patient Symptoms Class I (mild) No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, or dyspnea. Class II (mild) Slight limitation of physical activity. Comfortable at rest, but ordinary physical activity results in fatigue, palpitation, or dyspnea. Class III (moderate) Marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes fatigue, palpitation, or dyspnea. Class IV (severe) Unable to carry out any physical activity without discomfort. Symptoms of cardiac insufficiency at rest. If any physical activity is undertaken, discomfort is increased. Characterizations of Heart Failure CLASSES BY SEVERITY OF SYMPTOMS COMMONLY CITED: NEW YORK HEART ASSOCIATION FUNCTION CLASSIfiCATIONS:1 1The Criteria Committee of the New York Heart Association. Diseases of the Heart and Blood Vessels: Nomenclature and Criteria for Diagnosis. 6th edition. Boston, MA: Little Brown, 1964.
  • 19. AdvancingDialysis.org ESRD “Reactive” Classification System ADQI DYSPNEA ASSESSMENT • Dyspnea pre and post hemodialysis treatment assessment • Class assignment assumes the achievement of dry weight and usual level of pre/post dyspnea • Patients scored by their post- treatment dyspnea assessment: ‒ If dyspnea symptoms improve to class I levels, the patient would be classified as class 2R ‒ If dyspnea symptoms improve to class II levels, the patient would be classified as class 3R. Chawla LS, Herzog CA, Costanzo MR et al. Proposal for a Functional Classification System of Heart Failure in Patients With End-Stage Renal Disease. J Am Coll Cardiol 2014;63:1246–52
  • 20. AdvancingDialysis.org NKF-KDOQI HEMODIALYSIS ADEQUACY GUIDELINE: 2015 UPDATE Consider additional hemodialysis sessions or longer hemodialysis treatment times for patients with: • Large weight gains • High ultrafiltration rates • Poorly controlled blood pressure • Difficulty achieving dry weight • Poor metabolic control (such as hyperphosphatemia, metabolic acidosis, and/or hyperkalemia) • Inadequate sodium/water removal to manage hypertension, hypervolemia, and left ventricular hypertrophy National Kidney Foundation. KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update. Am J Kidney Dis. 2015;66(5):884-930.
  • 21. AdvancingDialysis.org Home Dialysis Utilization INCREASE IN NUMBER OF HOME DIALYSIS PATIENTS *USRDS 2017 ADR Reference Table D.1: Percentages & counts of reported ESRD patients: by treatment modality 28,317 28,955 36,083 46,772 51,057 2,081 4,378 7,049 8,523 8,987 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 US HOME DIALYSIS PATIENTS Peritoneal Dialysis Home hemodialysis HOME DIALYSIS UTILIZATION: REMAINS <12% OF PATIENTS
  • 22. AdvancingDialysis.org Addressing Consistent Volume Control INCREASED TREATMENT TIME AND FREQUENCY *See references on slides 28-30 Clinical Considerations for Number of Hemodialysis Treatments per Week:* 3 Tx 3.5 – 4 Tx 5+ Tx (“Daily”) 5+ Tx (“Nocturnal”) • Longer hemodialysis treatment time (ex. nocturnal treatments) has improved mortality in observational studies1 • Could mitigate the 2-day killer gap2 • Possibility to decrease UFR with 2-3 additional hours of time per treatment3,4 • Improved BP control & survival1,4-8 • Reduced LVH & cardiovascular hospitalizations4,7,8,10 • Reduced UFR, recovery time & hypotensive episodes3-5,10-15 • Improvements in sleep quality, RLS & HRQoL5,16-18 • Limits volume loading between treatments Benefits from 5+ days per week plus: • Improved sleep and obstructive sleep apnea14,17 • Best dialytic PO4 control4,20,21 • Increased reduction in post dialysis recovery time15
  • 23. AdvancingDialysis.org Broader context as summarized by Dr. Allan J. Collins: Trends in the US Dialysis population: • Rate of growth of the US dialysis has slowed to less than 2% per year • Progress on reducing death rates has not only slowed, but stagnated from 2014 to 2016 • US hospitalization rates flattened with expanding use of emergency room visits and observation stays is a new, major concern • Cardiovascular disease and infection remain the leading causes of hospital visits with little progress in recent years • Long weekend, interdialytic interval is a risk for death and hospitalization on the first run of the week • How are these populations going to be managed to reduce morbidity, mortality and cost over the coming decade with shortages of physicians, nurses and inflationary costs? Dr. Collins has held several leadership roles at the National Kidney Foundation (NKF), serving as president for two years, and on the NKF scientific advisory board for six years, and with the Kidney Dialysis Outcomes Quality Initiative. Dr. Collins is the Chief Medical Officer for NxStage Medical, Inc.
  • 24. AdvancingDialysis.org Critical, unmet needs in current dialysis patient care: ‒ Chronic fluid overload ‒ Aggressive ultrafiltration rates ‒ Recovery time ‒ Cardiovascular-related hospitalizations and death • Reactive classifications and care pose challenges to adequate interventions to treat heart disease and cardiovascular complications • Multiple randomized clinical trials and large observational cohort studies have shown hemodialysis that 5 or 6 sessions per week can positively address heart disease • Proactive disease management should be our aim for current and future patients entrusted to our care Dr. Collins has held several leadership roles at the National Kidney Foundation (NKF), serving as president for two years, and on the NKF scientific advisory board for six years, and with the Kidney Dialysis Outcomes Quality Initiative. Dr. Collins is the Chief Medical Officer for NxStage Medical, Inc.
  • 25. AdvancingDialysis.org Proactive for either secondary or primary prevention of cardiovascular disease: • Transplant candidates  ‒ Poor control of CVD and BMD while on waitlist could be alleviated with more frequent treatments • Pregnant patients  ‒ Physiologic volume-loaded state is best treated with more frequent hemodialysis ‒ Long-term health of the mother should be a rationale for more frequent and longer treatments • Sleep apnea patients  ‒ Likely represents a volume loaded state with central edema, hypoxia and pulmonary hypertension with right heart overload ‒ Could be mitigated with more frequent or nocturnal hemodialysis • Restless leg syndrome patients  ‒ Likely represents persistent uremia toxins nervous system toxicity which is treated with more frequent hemodialysis • Hyper oxalosis patients  ‒ Best treated with maximum long nocturnal, daily hemodialysis therapy
  • 26. AdvancingDialysis.org About this presentation This presentation is one in an ongoing series focused on recent articles, clinical findings or guidelines related to issues affecting dialysis patients. AdvancingDialysis.org is dedicated to providing clinicians and patients with better access to and more awareness of the reported clinical benefits and improved quality of life made possible with home dialysis, including solo and nocturnal therapy schedules. For more information, visit AdvancingDialysis.org AdvancingDialysis.org is a project of NxStage Medical, Inc.
  • 27. AdvancingDialysis.org Risks and Responsibilities Not everyone will experience the reported benefits of home and more frequent hemodialysis. All forms of hemodialysis involve some risks. When vascular access is exposed to more frequent use, infection of the site, and other access related complications may also be potential risks. Certain risks associated with hemodialysis treatment are increased when performing solo home hemodialysis because no one is present to help the patient respond to health emergencies. Certain risks associated with hemodialysis treatment are increased when performing nocturnal therapy due to the length of treatment time and because the patient and care partner are sleeping.
  • 28. AdvancingDialysis.org Clinical Evidence for Benefits Of Increased Frequency at Home REFERENCES 1Rivara MB et al. Extended-hours hemodialysis is associated with lower mortality risk in patients with end-stage renal disease. Kidney Int. 2016 Dec;90(6):1312-1320. 2Foley, R. N., Gilbertson, D. T., Murray, T., Collins, A. J. Long interdialytic interval and mortality among patients receiving hemodialysis. NEJM. 2011;365(12):1099-1107. 3Raimann, J.G., et al. The Effect of Increased Frequency of Hemodialysis on Volume-Related Outcomes: A Secondary Analysis of the Frequent Hemodialysis Network Trials. Blood Purif 2016;41:277–286. 4FHN Trial Group, Chertow, G.M., Levin, N.W., Beck, G.J. et al. In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010; 363: 2287–2300. 5Morfin, J.A., Fluck, R.J., Weinhandl, E.D., Kansal, S., McCullough, P.A., and Komenda, P. Intensive hemodialysis and treatment complications and tolerability. Am J Kidney Dis. 2016; 68: S43–S50. 6Bakris, G.L., Burkart, J.M., Weinhandl, E.D., McCullough, P.A., and Kraus, M.A. Intensive hemodialysis, blood pressure, and antihypertensive medication use. Am J Kidney Dis. 2016; 68: S15–S23. 7Weinhandl ED, Gilbertson DT, Collins AJ. Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study. Am J Kidney Dis. 2016;67(1):98-110. 8Weinhandl, E.D., Liu, J., Gilbertson, D.T., Arneson, T.J., Collins, A.J. Survival in daily home hemodialysis and matched thrice- weekly in-center hemodialysis patients. J Am Soc Nephrol. 2012;23:895–904. 9Chan, C.T., Greene, T., Chertow, G.M. et al. Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials. Circ Cardiovasc Imaging. 2012; 5: 251–261.
  • 29. AdvancingDialysis.org 10McCullough, P.A., Chan, C.T., Weinhandl, E.D., Burkart, J.M., and Bakris, G.L. Intensive hemodialysis, left ventricular hypertrophy, and cardiovascular disease. Am J Kidney Dis. 2016; 68: S5–S14. 11Weinhandl, Collins, Kraus. Ultrafiltration Rates with More Frequent Home Hemodialysis. Oral Presentation. 2017 ADC. 12Stefánsson, B.V., Brunelli, S.M., Cabrera, C. et al. Intradialytic hypotension and risk of cardiovascular disease. Clin J Am Soc Nephrol. 2014; 9: 2124–2132. 13Jefferies, H.J., et al. Frequent Hemodialysis Schedules Are Associated with Reduced Levels of Dialysis-induced Cardiac Injury (Myocardial Stunning). Clin J Am Soc Nephrol. 2011 June; 6(6): 1326–1332. 14Jaber BL, Lee Y, Collins AJ, et al. Effect of daily hemodialysis on depressive symptoms and postdialysis recovery time: interim report from the FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements) Study. Am J Kidney Dis. 2010;56(3):531-539. 15Lindsay RM, Heidenheim PA, Nesrallah G, Garg AX, Suri R, Daily Hemodialysis Study Group London Health Sciences Centre. Minutes to recovery after a hemodialysis session: a simple health-related quality of life question that is reliable, valid, and sensitive to change. CJASN. 2006;1(5):952-959. 16Jaber BL, et al. Impact of Short Daily Hemodialysis on Restless Legs Symptoms and Sleep Disturbances. CJASN May 2011 vol. 6 no. 5 1049-1056. 17Finkelstien FO, et al. At-home short daily hemodialysis improves the long-term health-related quality of life. Kidney International (2012) 82, 561–569. 18Kraus, Michael A. et al. Intensive Hemodialysis and Health-Related Quality of Life. Am J of Kidney Dis. 2016;68:S33-S42. Clinical Evidence for Benefits Of Increased Frequency at Home REFERENCES
  • 30. AdvancingDialysis.org 19Hanley, P.J., Pierratos, A. Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med: 2001; Vol. 344, No. 2. 20Daugirdas JT, Chertow GM, Larive B, et al. Effects of frequent hemodialysis on measures of CKD mineral and bone disorder. JASN. 2012;23(4):727-738. 21Copland, M. et al. Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use. Am J Kid D: 2016; Volume 68, Issue 5, Supplement 1, Pages S24–S32. Clinical Evidence for Benefits Of Increased Frequency at Home REFERENCES

Editor's Notes

  1. New
  2. Combine 4 & 5 into 1 slide
  3. Remove PD, add 2nd axis with percentage change YOY, combine 6 & 7
  4. Add all dialysis only and transplant only due to opiate deaths
  5. 2 panel slide, this data smaller chart
  6. Chronic Fluid Overload: The highest priority to address Unmet Need Persistent hypertension and fluid overload are in the causal path for LVH and heart failure Controlling fluid overload requires UFR on dialysis to be tolerable but may be challenging with conventional HD Hypotension on dialysis limits the use of cardioprotective medicines UFRs are related to cardiac stunning UFRs are associated with recovery time Controlling and reducing the UFR to achieve the desired volume control are challenging with conventional HD
  7. Fluid removal rate is associated with increase mortality risk down to <6ml/kg/hr Controlling fluid overload requires UFR on dialysis to be tolerable but may be challenging with conventional HD Hypotension on dialysis limits the use of cardioprotective medicines
  8. Conventional dialysis needs to change to address the unmet need directed at volume control Risk factor awareness, treatment and control is needed in the dialysis population to address the chronic progressive CVD Chronic Fluid Overload associated with higher risk of death
  9. Reactive care Define patient not tolerating therapy: SOB, DOE, Orthopnea, PND (HF or Fluid Overload) Hypotension, Cramps, Post treatment prolonged recovery time Persistent hypertension greater 140/90 for 3-6 months, greater than 2-3 meds LVH with or without reduced systolic function, LVM >125gm/m2, NYHA class 2-4 CHF, consistently and persistently elevation NP-Pro BNP, elevated troponins, Persistently high PO4 (5.5+ mg/dl) for 3-6 months PD failures with volume overload
  10. Start 2005 +
  11. More Frequent HD limits volume loading between treatments Reduces the long weekend loading associated with higher morbidity and mortality UFRs are slower enabling vascular refilling reducing hypotension MFHD consistently improves blood pressure control and decreases the use of anti-hypertensive medication without increasing complications on dialysis Intensive BP control on conventional dialysis requires more medications and creates greater intra-dialytic complications
  12. Changed color – APM2302